How big is the Anti-venom Market?

The Anti-venom Market size is expected to reach USD 1.20 billion in 2024 and grow at a CAGR of 3.13% to reach USD 1.40 billion by 2029. Read More

What is the current Anti-venom Market size?

In 2024, the Anti-venom Market size is expected to reach USD 1.20 billion. Read More

Who are the key players in Anti-venom Market?

Pfizer Inc., Merck KGaA (Sigma Aldrich), Boehringer Ingelheim, CSL Limited and Bharat Serums and Vaccines Ltd are the major companies operating in the Anti-venom Market. Read More

Which is the fastest growing region in Anti-venom Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Anti-venom Market?

In 2024, the North America accounts for the largest market share in Anti-venom Market. Read More

What years does this Anti-venom Market cover, and what was the market size in 2023?

In 2023, the Anti-venom Market size was estimated at USD 1.16 billion. The report covers the Anti-venom Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Anti-venom Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Anti Venom Market - Trends, Growth & Size

Anti Venom Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Anti Venom Drugs Market Insights and It is Segmented by Species (Snake, Scorpion, Spiders, and Other Species), Anti-Venom Type (Polyvalent Anti-Venoms, Monovalent Anti-Venom, and Other Anti-Venom Types), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Size and Forecasts are Provided in Terms of Value (USD Million) for all the Above Segments.

Anti-Venom Industry Overview

The anti-venom market is competitive, and consists of several market players. Most developing countries with established biotechnological facilities have local scientific expertise, which creates favorable conditions and the atmosphere to establish local anti-venom manufacturing practices. Countries such as Brazil, Costa Rica, Egypt, France, India, Mexico, South Africa, and Thailand have large, well-established anti-venom manufacturers. The major market players operating in the anti-venom market include BTG PLC, Pfizer Inc., Merck KGaA (Sigma Aldrich), Boehringer Ingelheim, and CSL Limited, among others.